STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study
PHASE1CompletedINTERVENTIONAL
Enrollment
31
Participants
Timeline
Start Date
January 31, 2007
Primary Completion Date
June 30, 2008
Study Completion Date
June 30, 2008
Conditions
Genotype Guided(HNF4a)Healthy Subjects
Interventions
DRUG
Tolterodine
All Listed Sponsors
lead
Inje University
OTHER
NCT01181505 - STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study | Biotech Hunter | Biotech Hunter